CBD Epilepsy

In 2023, São Paulo enacted a law enabling the dispensing of cannabidiol (CBD)-based medicines across public and private health facilities associated with the Brazilian Unified Health System in Brazil’s most populous state with more than 44 million people. The law made CBD-based medicine...

If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your parent's love, you must raise children yourself.' Today's story is about a mother who once moved mountains for her daughter and continues...

An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol, or CBD, can inhibit infection by the COVID-19 virus in human cells and in mice. They caution, however, that the COVID-blocking effects of CBD come only from a high-purity, specially...

Avicanna Inc., (TSX: AVCN) (OTCQX: AVCNF) a biopharmaceutical company focused on cannabinoid-based medicines, has filed a provisional patent application that aims to patent the use of a novel cannabinoid formulation for reducing or eliminating seizures and sudden death in epilepsy. Encompassed in...

Charlotte Figi, a young girl from Colorado, who helped spread the word about the benefits of CBD in those suffering from rare forms of epilepsy, will never be forgotten. This week, on April 7th, a benefit concert in her honor will be held in her memory. Charlotte's Story Charlotte became famous...

GW Pharmaceuticals plc (NASDAQ: GWPH) released Monday preliminary unaudited financial results. Net sales for the company's fourth-quarter are expected to be around $148 million. For the full year, GW anticipates net sales of $526 million while its total Epidolex...

The U.S. Food and Drug Administration on Monday announced the approval of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)’s cannabidiol-based Epidiolex for the treatment of two rare childhood-onset forms of epilepsy that are commonly treatment-resistant. “The acknowledgement by the FDA of...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...